{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:59:50Z","timestamp":1773349190695,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe \u00dcniversitesi","doi-asserted-by":"publisher","award":["06 01 101 021"],"award-info":[{"award-number":["06 01 101 021"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00381-018-3745-6","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T02:40:09Z","timestamp":1518835209000},"page":"877-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Heightened CXCR4 and CXCL12 expression in NF1-associated neurofibromas"],"prefix":"10.1007","volume":"34","author":[{"given":"Beren","family":"Karaosmanoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c7etin Y.","family":"Kocaefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"S\u00f6ylemezo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Anlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Varan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130brahim","family":"Vargel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00fckriye","family":"Ayter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"3745_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1542\/peds.2007-3204","volume":"123","author":"VC Williams","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123:124\u2013133","journal-title":"Pediatrics"},{"key":"3745_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","volume":"61","author":"KP Boyd","year":"2009","unstructured":"Boyd KP, Korf BR, Theos A (2009) Neurofibromatosis type 1. J Am Acad Dermatol 61:1\u201316","journal-title":"J Am Acad Dermatol"},{"key":"3745_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0090-3019(97)00356-X","volume":"51","author":"MM Feldkamp","year":"1999","unstructured":"Feldkamp MM, Angelov L, Guha A (1999) Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. Surg Neurol 51:211\u2013218","journal-title":"Surg Neurol"},{"key":"3745_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00401-011-0928-6","volume":"123","author":"SL Carroll","year":"2011","unstructured":"Carroll SL (2011) Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms. Acta Neuropathol 123:321\u2013348","journal-title":"Acta Neuropathol"},{"key":"3745_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1182\/blood-2009-09-242875","volume":"116","author":"K Staser","year":"2010","unstructured":"Staser K, Yang FC, Clapp DW (2010) Mast cells and the neurofibroma microenvironment. Blood 116:157\u2013164","journal-title":"Blood"},{"key":"3745_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","volume":"104","author":"K Cichowski","year":"2001","unstructured":"Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104:593\u2013604","journal-title":"Cell"},{"key":"3745_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/neuonc\/nos287","volume":"15","author":"M Kolberg","year":"2013","unstructured":"Kolberg M, H\u00f8land M, Agesen TH, Brekke HR, Liest\u00f8l K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA (2013) Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro Oncology 15:135\u2013147","journal-title":"Neuro Oncology"},{"key":"3745_CR8","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1039\/c2cs35085h","volume":"41","author":"J Kuil","year":"2012","unstructured":"Kuil J, Buckle T, van Leeuwen FWB (2012) Imaging agents for the chemokine receptor 4 (CXCR4). Chem Soc Rev 41:5239\u20135261","journal-title":"Chem Soc Rev"},{"key":"3745_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/31269","volume":"393","author":"YR Zou","year":"1998","unstructured":"Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595\u2013599","journal-title":"Nature"},{"key":"3745_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.cell.2013.01.053","volume":"152","author":"W Mo","year":"2013","unstructured":"Mo W, Chen J, Patel A, Zhang L, Chau V, Li Y, Cho W, Lim K, Xu J, Lazar AJ, Creigton CJ, Bolshakov S, McKay RM, Lev D, Le LQ, Parada LF (2013) CXCR4\/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors. Cell 152:1077\u20131090","journal-title":"Cell"},{"key":"3745_CR11","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","volume":"107","author":"JA Burger","year":"2006","unstructured":"Burger JA, Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761\u20131767","journal-title":"Blood"},{"key":"3745_CR12","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/bjc.2011.169","volume":"104","author":"D Tseng","year":"2011","unstructured":"Tseng D, Vasquez-Medrano DA, Brown JM (2011) Targeting SDF-1\/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas. Br J Cancer 104:1805\u20131809","journal-title":"Br J Cancer"},{"key":"3745_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cytogfr.2012.08.007","volume":"24","author":"AK Singh","year":"2012","unstructured":"Singh AK, Arya RK, Trivedi AK, Sanyal S, Baral R, Dormond O, Briscoe DM, Datta D (2012) Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. Cytokine Growth Factor and Reviews 24:41\u201349","journal-title":"Cytokine Growth Factor and Reviews"},{"key":"3745_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1593\/neo.12324","volume":"14","author":"UM Domanska","year":"2012","unstructured":"Domanska UM, Timmer-Bosscha H, Nagengast WB, Munnink THO, Kruizinga RC, Ananias HJK, Kliphuis NM, Huls G, De Vries EG, de Jong IJ, Walenkamp AM (2012) CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Neoplasia 14:709\u2013718","journal-title":"Neoplasia"},{"key":"3745_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.stem.2009.03.017","volume":"4","author":"LQ Le","year":"2009","unstructured":"Le LQ, Shipman T, Burns DK, Parada LF (2009) Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. Cell Stem Cell 4:453\u2013463","journal-title":"Cell Stem Cell"},{"key":"3745_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ejhg.2011.207","volume":"20","author":"L Thomas","year":"2012","unstructured":"Thomas L, Spurlock G, Eudall C, Thomas NS, Most M, Hamby SE, Chuzhanova N, Brems H, Legius E, Cooper DN, Upadhyaya M (2012) Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas. Eur J Hum Genet 20:411\u2013419","journal-title":"Eur J Hum Genet"},{"key":"3745_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1477-7819-10-212","volume":"10","author":"L Wang","year":"2012","unstructured":"Wang L, Chen W, Gao L, Yang Q, Liu B, Wu Z, Wang Y, Sun Y (2012) High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma. World Journal of Surgical Oncology 10:212\u2013219","journal-title":"World Journal of Surgical Oncology"},{"key":"3745_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/01913123.2012.728687","volume":"36","author":"M Zhang","year":"2012","unstructured":"Zhang M, Liu H, Teng X, Wang H, Cui J, Jia SS, Gu XY, Li ZG (2012) The differences in CXCR4 protein expression are significant for the five molecular subtypes of breast cancer. Ultrastruct Pathol 36:381\u2013386","journal-title":"Ultrastruct Pathol"},{"key":"3745_CR19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/glia.22669","volume":"62","author":"F Gagliardi","year":"2014","unstructured":"Gagliardi F, Narayanan A, Reni M, Franzin A, Mazza E, Boari N, Balio M, Zordan P, Mortini P (2014) The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions. Glia 62:1015\u20131023","journal-title":"Glia"},{"key":"3745_CR20","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","volume":"375","author":"E Dombi","year":"2016","unstructured":"Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim AR, Whitcomb P, Martin S, Aschbacher-Smith LE, Rizvi TA, Wu J, Ershler R, Wolters P, Therrien J, Glod J, Belasco JB, Schorry E, Brofferio A, Starosta AJ, Gillespie A, Doyle AL, Ratner N, Widemann BC (2016) Activity of selumetinib in neurofibromatosis type 1\u2013related plexiform neurofibromas. N Engl J Med 375:2550\u20132560","journal-title":"N Engl J Med"},{"key":"3745_CR21","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","volume":"13","author":"AC Hirbe","year":"2014","unstructured":"Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. The Lancet Neurology 13:834\u2013843","journal-title":"The Lancet Neurology"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-018-3745-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-018-3745-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-018-3745-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T22:32:08Z","timestamp":1550356328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-018-3745-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3745"],"URL":"https:\/\/doi.org\/10.1007\/s00381-018-3745-6","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"7 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}